KALA BIO (KALA)
NASDAQ:KALA
Want to see KALA full AI Analyst Report?
Total Valuation
KALA BIO has a market cap or net worth of $49.26M. The enterprise value is $55.25M.
Market Cap$49.26M
Enterprise Value$55.25M
Share Statistics
KALA BIO has 18,589,832 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,589,832
Owned by Insiders3.97%
Owned by Institutions―
Financial Efficiency
KALA BIO’s return on equity (ROE) is -3.86 and return on invested capital (ROIC) is -559.76%.
Return on Equity (ROE)-3.86
Return on Assets (ROA)-2.84
Return on Invested Capital (ROIC)-559.76%
Return on Capital Employed (ROCE)-5.60
Revenue Per Employee0.00
Profits Per Employee-710.00K
Employee Count38
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of KALA BIO is ―. KALA BIO’s PEG ratio is 0.16.
PE Ratio―
PS Ratio0.00
PB Ratio32.38
Price to Fair Value32.38
Price to FCF-7.08
Price to Operating Cash Flow-0.81
PEG Ratio0.16
Income Statement
In the last 12 months, KALA BIO had revenue of 0.00 and earned -26.98M in profits. Earnings per share was -3.31.
Revenue0.00
Gross Profit0.00
Operating Income-39.16M
Pretax Income-26.98M
Net Income-26.98M
EBITDA-23.39M
Earnings Per Share (EPS)-3.31
Cash Flow
In the last 12 months, operating cash flow was -26.06M and capital expenditures 0.00, giving a free cash flow of -26.06M billion.
Operating Cash Flow-26.06M
Free Cash Flow-26.06M
Free Cash Flow per Share-1.40
Dividends & Yields
KALA BIO pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.66
52-Week Price Change-98.73%
50-Day Moving Average7.92
200-Day Moving Average141.10
Relative Strength Index (RSI)20.89
Average Volume (3m)1.94M
Important Dates
KALA BIO upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateMay 19, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
KALA BIO as a current ratio of 3.81, with Debt / Equity ratio of 0.00%
Current Ratio3.81
Quick Ratio3.81
Debt to Market Cap0.00
Net Debt to EBITDA0.32
Interest Coverage Ratio-11.95
Taxes
In the past 12 months, KALA BIO has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
KALA BIO EV to EBITDA ratio is -9.36, with an EV/FCF ratio of -6.84.
EV to Sales0.00
EV to EBITDA-9.36
EV to Free Cash Flow-6.84
EV to Operating Cash Flow-6.84
Balance Sheet
KALA BIO has $8.76M in cash and marketable securities with $0.00 in debt, giving a net cash position of $8.76M billion.
Cash & Marketable Securities$8.76M
Total Debt$0.00
Net Cash$8.76M
Net Cash Per Share$0.47
Tangible Book Value Per Share$0.86
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for KALA BIO is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast66.47%